Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | ARAZLO Lotion 0.045% |
Description | Clearer skin is possible with ARAZLO Lotion. Learn more about ARAZLO Lotion. |
Keywords | Arazlo, arazlo lotion, tazarotene lotion, acne treatment, prescription treatment for acne, retinoid acne treatment, tazarotene acne treatment, prescribed arazlo |
WebSite | www.arazlo.com |
Host IP | 45.60.73.248 |
Location | United States |
Site | Rank |
US$11,100
Last updated: Aug 24, 2020
Arazlo.com has global traffic rank of 4,578,272. Arazlo.com has an estimated worth of US$ 11,100, based on its estimated Ads revenue. Arazlo.com receives approximately 675 unique visitors each day. Its web server is located in United States, with IP address 45.60.73.248. According to SiteAdvisor, arazlo.com is safe to visit. |
Purchase/Sale Value | US$11,100 |
Daily Ads Revenue | US$6 |
Monthly Ads Revenue | US$182 |
Yearly Ads Revenue | US$2,220 |
Daily Unique Visitors | 675 |
Note: All traffic and earnings values are estimates. |
Global Rank | 4,578,272 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
arazlo.com | A | 3599 | IP: 45.60.109.248 |
arazlo.com | A | 3599 | IP: 45.60.73.248 |
arazlo.com | NS | 21599 | Target: ns2.markmonitor.com. |
arazlo.com | NS | 21599 | Target: ns5.markmonitor.com. |
arazlo.com | NS | 21599 | Target: ns4.markmonitor.com. |
arazlo.com | NS | 21599 | Target: ns7.markmonitor.com. |
arazlo.com | NS | 21599 | Target: ns6.markmonitor.com. |
arazlo.com | NS | 21599 | Target: ns3.markmonitor.com. |
arazlo.com | NS | 21599 | Target: ns1.markmonitor.com. |
arazlo.com | SOA | 21599 | MNAME: ns1.markmonitor.com. RNAME: hostmaster.markmonitor.com. Serial: 2019110701 Refresh: 86400 Retry: 3600 Expire: 2592000 Minimum TTL: 172800 |
HTTP/1.1 301 Moved Permanently Location: https://www.arazlo.com/ Content-Length: 0 Connection: close HTTP/1.1 200 OK Cache-Control: no-cache Pragma: no-cache Content-Type: text/html; charset=utf-8 Expires: -1 Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly Set-Cookie: language=en-US; path=/; HttpOnly Set-Cookie: .ASPXANONYMOUS=lmw-265ktXpHVtbyIq9TH8lYZ5UfG9BvoIRFEAwd0xtu1bjnjamkyKHg7r-OJDtoSE-E7UrAKg_D88Fsenp38mAgU9r-nW9Wa1tChA7YKOAn475k0; expires=Sun, 01-Nov-2020 16:16:29 GMT; path=/; HttpOnly Set-Cookie: Analytics_VisitorId=8b2d1c77-6879-4091-87ab-ccfc26422792; expires=Wed, 23-Sep-2020 05:36:29 GMT; path=/; HttpOnly Set-Cookie: Analytics=SessionId=4b46a693-ad55-46ed-9c57-6eef3833efc8&TabId=12913&ContentItemId=-1; expires=Mon, 24-Aug-2020 06:36:29 GMT; path=/; HttpOnly X-UA-Compatible: IE=edge Set-Cookie: dnn_IsMobile=False; path=/; HttpOnly Set-Cookie: language=en-US; path=/; HttpOnly Set-Cookie: .ASPXANONYMOUS=lmw-265ktXpHVtbyIq9TH8lYZ5UfG9BvoIRFEAwd0xtu1bjnjamkyKHg7r-OJDtoSE-E7UrAKg_D88Fsenp38mAgU9r-nW9Wa1tChA7YKOAn475k0; expires=Sun, 01-Nov-2020 16:16:29 GMT; path=/; HttpOnly Set-Cookie: Analytics_VisitorId=8b2d1c77-6879-4091-87ab-ccfc26422792; expires=Wed, 23-Sep-2020 05:36:29 GMT; path=/; HttpOnly Set-Cookie: Analytics=SessionId=4b46a693-ad55-46ed-9c57-6eef3833efc8&TabId=12913&ContentItemId=-1; expires=Mon, 24-Aug-2020 06:36:29 GMT; path=/; HttpOnly Set-Cookie: __RequestVerificationToken=x3xbdn7A3T7aTUPPXmLswxljfqzNgB17gDM918CSikJ2jP-9a0Q4-uor023ZeDfQc-K_fQ2; path=/; HttpOnly X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN Date: Mon, 24 Aug 2020 05:36:29 GMT Set-Cookie: visid_incap_2184045=uTfU90MDSKu/txZpZtH1Ed1RQ18AAAAAQUIPAAAAAAA1ZdppijM/rbMJWxqme9p3; expires=Mon, 23 Aug 2021 08:56:34 GMT; HttpOnly; path=/; Domain=.arazlo.com Set-Cookie: nlbi_2184045=akidJqUrI1nDPffVgkRhbgAAAAC9R/BHtIpRUzBrTUG5S7JX; path=/; Domain=.arazlo.com Set-Cookie: incap_ses_1170_2184045=22sXIWB3H3YNQU255qw8EN1RQ18AAAAADEgG8+JhijH/EKn+MI9QyA==; path=/; Domain=.arazlo.com Set-Cookie: ___utmvmsFBuEkiZZ=zJXtZdFFSfU; path=/; Max-Age=900 Set-Cookie: ___utmvasFBuEkiZZ=zYJGztJ; path=/; Max-Age=900 Set-Cookie: ___utmvbsFBuEkiZZ=WZI XKHOUalv: utu; path=/; Max-Age=900 X-CDN: Incapsula Transfer-Encoding: chunked X-Iinfo: 11-53456967-53456992 NNNN CT(18 58 0) RT(1598247388991 14) q(0 0 1 54) r(2 2) U12 |
Domain Name: ARAZLO.COM Registry Domain ID: 2298159284_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-07-16T10:09:42Z Creation Date: 2018-08-16T18:03:35Z Registry Expiry Date: 2022-08-16T18:03:35Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: arazlo.com Registry Domain ID: 2298159284_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-07-16T03:09:42-0700 Creation Date: 2018-08-16T11:03:35-0700 Registrar Registration Expiration Date: 2022-08-16T00:00:00-0700 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895770 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Registrant Organization: Valeant Pharmaceuticals North America LLC Registrant State/Province: NJ Registrant Country: US Registrant Email: Select Request Email Form at https://domains.markmonitor.com/whois/arazlo.com Admin Organization: Valeant Pharmaceuticals North America LLC Admin State/Province: NJ Admin Country: US Admin Email: Select Request Email Form at https://domains.markmonitor.com/whois/arazlo.com Tech Organization: Valeant Pharmaceuticals North America LLC Tech State/Province: NJ Tech Country: US Tech Email: Select Request Email Form at https://domains.markmonitor.com/whois/arazlo.com Name Server: ns4.markmonitor.com Name Server: ns3.markmonitor.com Name Server: ns6.markmonitor.com Name Server: ns2.markmonitor.com Name Server: ns7.markmonitor.com Name Server: ns5.markmonitor.com Name Server: ns1.markmonitor.com DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ MarkMonitor Domain Management(TM) Protecting companies and consumers in a digital world. Visit MarkMonitor at https://www.markmonitor.com Contact us at +1.8007459229 In Europe, at +44.02032062220 |